Moderna Stock Goes Up 160% on “Fluff Nonsense” About an mRNA Cancer Vaccine

Imagine buying Moderna MRNA 42.73%↑ after it’s gone up 160%, not knowing that:

1. The first person in the world who took Moderna’s mRNA-4157 Cancer vaccine outside of Clinical Trials died recently with no improvement – he was a jabbed Australian Cancer Researcher (@ProfRAScolyer).

2. Moderna’s mRNA Cancer Vaccine is actually 18 to 27 injections (Phase 2 had 27 injections, Phase 3 had 18).

3. Moderna’s mRNA Cancer Vaccine has an up to 36% severe side effect rate (Grade 3+).

4. Moderna didn’t actually give us any results of their Phase 3 INTerpath-001 Trial and Phase 2 results were underwhelming at best.

5. Merck actually takes 50% of the profit of every Moderna mRNA Cancer Vaccine sold.

This was a Big Pharma bot driven news day with no substance whatsoever.

If you bought low, this was an excellent dead cat bounce as far as a stock move is concerned, but that’s all this is.

There is no “cure for cancer” here, sorry to say.

.

*

Click the share button below to email/forward this article. Follow us on Instagram and X and subscribe to our Telegram Channel. Feel free to repost Global Research articles with proper attribution.

Dr. William Makis is a Canadian physician with expertise in Radiology, Oncology and Immunology. Governor General’s Medal, University of Toronto Scholar. Author of 100+ peer-reviewed medical publications.

Global Research is a reader-funded media. We do not accept any funding from corporations or governments. Help us stay afloat. Click the image below to make a one-time or recurring donation.